Patents by Inventor Lisa Ware

Lisa Ware has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Recombinant merozoite protein-1 p42 vaccine
    Patent number: 7150875
    Abstract: In this application is the expression and purification of a recombinant Plasmodium vivax (SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Grant
    Filed: March 18, 2002
    Date of Patent: December 19, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware
  • Plasmodium falciparum AMA-1 protein and uses thereof
    Publication number: 20060264619
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a protein for use alone, or as part of, a vaccine to prevent malaria.
    Type: Application
    Filed: January 13, 2006
    Publication date: November 23, 2006
    Inventors: David Lanar, Sheetij Dutta, Lisa Ware, Lalitha Nair
  • AMA-1 protein and uses thereof
    Patent number: 7060276
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Grant
    Filed: March 25, 2002
    Date of Patent: June 13, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware, Lalitha P. V. Nair
  • AMA-1 protein and uses thereof
    Patent number: 7029685
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a protein for use alone, or as part of, a vaccine to prevent malaria.
    Type: Grant
    Filed: October 15, 2002
    Date of Patent: April 18, 2006
    Assignee: The United States of America as represented by the Secretary of the Army
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware, Lalitha P. V. Nair
  • Recombinant P. vivax merozoite protein-1 p42 vaccine
    Publication number: 20030157650
    Abstract: In this application is the expression and purification of a recombinant Plasmodium vivax (SalI) PvMSP-1 p42. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant PvMSP-1 p42 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Application
    Filed: March 18, 2002
    Publication date: August 21, 2003
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware
  • Plasmodium falciparum AMA-1 protein and uses thereof
    Publication number: 20030138450
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a protein for use alone, or as part of, a vaccine to prevent malaria.
    Type: Application
    Filed: October 15, 2002
    Publication date: July 24, 2003
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware, Lalitha P.V. Nair
  • Plasmodium falciparum AMA-1 protein and uses thereof
    Publication number: 20030032787
    Abstract: In this application is described the expression and purification of a recombinant Plasmodium falciparum (3D7) AMA-1 ectodomain. The method of the present invention produces a highly purified protein which retains folding and disulfide bridging of the native molecule. The recombinant AMA-1 is useful as a diagnostic reagent, for use in antibody production, and as a vaccine.
    Type: Application
    Filed: March 25, 2002
    Publication date: February 13, 2003
    Inventors: David E. Lanar, Sheetij Dutta, Lisa A. Ware, Lalitha P.V. Nair